Gabriele Sauthier Romano de Melo

Gabriele Sauthier Romano de Melo

Auto-generated profile, based on publicly available information

Gabriele Sauthier Romano de Melo

Laboratory of Plant Biochemistry, Department of Biochemistry, State University of Maringá, Maringá, PR, 87020-900, Brazil

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2018 in Chemosphere
Verified
Journal Article
Closed access
TLTamires Letícia Cunha Lopes
Tamires Letícia Cunha Lopes
RSRita de Cássia Siqueira-Soares
Rita de Cássia Siqueira-Soares
GAGuilherme Henrique Gonçalves de Almeida
Guilherme Henrique Gonçalves de Almeida
GMGabriele Sauthier Romano de Melo
Gabriele Sauthier Romano de Melo
GBGabriela Ellen Barreto
Gabriela Ellen Barreto
RMRogério Marchiosi
Rogério Marchiosi

18 September 2017 in Acta Scientiarum. Biological Sciences
Verified
Journal Article
Open access
PDF file
GMGabriele Sauthier Romano de Melo
Gabriele Sauthier Romano de Melo
HSHerick Soares de Santana
Herick Soares de Santana
CTClaudenice Dei Tos
Claudenice Dei Tos
Ovarian histology and fecundity in the evaluation of the reproduction of the invasive species Serrasalmus marginatus (Characidae) on a neotropical floodplain

30 June 2025 in Journal of Biochemical and Molecular Toxicology
Verified
Journal Article
Open access
LNLetícia Fernanda Nanami
Letícia Fernanda Nanami
EKEduardo Makiyama Klosowski
Eduardo Makiyama Klosowski
MMMárcio Shigueaki Mito
Márcio Shigueaki Mito
GEGiovana Natiele Machado Esquissato
Giovana Natiele Machado Esquissato
GVGabriel Arcanjo Viana
Gabriel Arcanjo Viana
RCRodrigo Polimeni Constantin
Rodrigo Polimeni Constantin
This study evaluated the acute effects of morin on gluconeogenesis and glycogenolysis, key metabolic pathways that maintain glycemia, in perfused rat livers. It also assessed the acute effects of morin on mitochondrial energy metabolism and toxicity in hepatic cancer cells (HepG2) and renal epithelial cells (VERO), alongside its impact on the activity of key enzymes. Liver perfusion experiments assessed glucose fluxes, oxygen consumption, adenine nucleotide levels, and enzyme activities. Isolated mitochondria evaluated the effects of morin on oxidative phosphorylation. Enzymatic assays and MTT tests conducted in vitro determined the effects on hepatic enzymes and cell viability. In perfused rat livers, morin generally inhibited gluconeogenesis from various substrates, stimulated glycogenolysis and glycolysis, and altered oxygen consumption. Experiments on morin biotransformation suggested that this process may contribute to the inhibition of gluconeogenesis. Moreover, morin inhibited citric acid cycle activity under gluconeogenic conditions and reduced cellular ATP/ADP and ATP/AMP ratios under both gluconeogenic and glycogenolytic conditions. The elevated activity of cytosolic and mitochondrial enzymes in the effluent from perfused livers indicated impaired membrane integrity. In isolated rat liver mitochondria, morin inhibited the electron transport chain, the ATP/ADP exchange system, and functioned as an uncoupling agent of oxidative phosphorylation, thereby reducing ATP synthesis. Under in vitro conditions, morin inhibited the activity of glucose 6‐phosphatase, glucokinase, glucose 6‐phosphate dehydrogenase, and pyruvate kinase from rat livers. At the cellular level, morin decreased the viability of HepG2 and VERO cells, indicating its toxicity. The increased glucose release due to heightened glycogenolysis, combined with the suppression of gluconeogenesis, may impact the expected antihyperglycemic effects of morin. These outcomes were partly attributed to mitochondrial bioenergetic disruption, which is an important consideration for the therapeutic use of morin, particularly with prolonged treatment or higher doses. Together, these findings highlight morin's potential as an antihyperglycemic agent but also reveal significant concerns regarding its mitochondrial toxicity.

14 November 2025 in Plant Physiology and Biochemistry
Verified
Journal Article
Closed access
GMGabriele Sauthier Romano de Melo
Gabriele Sauthier Romano de Melo
ICIsabela de Carvalho Contesoto
Isabela de Carvalho Contesoto
MGMariane Gabrielly Greco
Mariane Gabrielly Greco
JSJean Jhonatan Seco da Silva
Jean Jhonatan Seco da Silva
ACAmanda Castro Comar
Amanda Castro Comar
RMRogério Marchiosi
Rogério Marchiosi

1 July 2026 in Revista Enfermagem Atual In Derme
Verified
Journal Article
Open access
PDF file
GMGabriele Sauthier Romano de Melo
Gabriele Sauthier Romano de Melo
MRMaicon Monteiro dos Reis
Maicon Monteiro dos Reis
JRJaqueline Monteiro dos Reis
Jaqueline Monteiro dos Reis
Introdução: A Doença Renal Crônica é definida como a alteração da função renal por um período maior que 3 meses consecutivos evidenciados por alterações nos biomarcadores da função renal mediante coleta de exames amostrais, configurando um quadro de piora da função renal e que vem tendo aumento da incidência ao longo dos últimos anos no Brasil, segundo o Boletim Epidemiológico. Objetivo: Identificar a característica do público prevalente e as fragilidades diante dos principais fatores associados à causa de Doença Renal Crônica no Brasil e no Mundo. Método: Trata-se de uma revisão integrativa de literatura, de caráter exploratório e descritivo, com abordagem qualitativa e emprego de questões norteadoras pertinentes para seleção e inclusão de estudos publicados entre 2021 e 2026. Resultados: 37 estudos foram incluídos, entre eles artigos e sites, com evidências nacionais e internacionais correlacionando Doença Renal Crônica com Hipertensão Arterial Sistêmica, Diabetes Mellitus, Obesidade, uso de cigarro eletrônico e idade avançada, associados à fatores sociais, individuais e comportamentais. Discussão: A presença das doenças de base configura importante fator determinante para o desenvolvimento de Doença Renal Crônica ao longo do tempo, e quando associado à fatores cardiovasculares, aumentam potencialmente as chances de desenvolver quadros avançados e com necessidade de Terapia Renal Substitutiva e mortalidade precoce. Considerações finais: A Atenção Primária à Saúde tem papel importante no controle das doenças de base e prevenção de Doença Renal Crônica, bem como na mudança da evolução epidemiológica nos próximos anos de forma a aumentar o monitoramento da população de risco.

8 January 2026 in Plant Physiology and Biochemistry
Verified
Journal Article
Open access
LGLuiz Henryque Escher Grizza
Luiz Henryque Escher Grizza
ICIsabela de Carvalho Contesoto
Isabela de Carvalho Contesoto
AMAna Paula da Silva Mendonça
Ana Paula da Silva Mendonça
ACAmanda Castro Comar
Amanda Castro Comar
ABAna Paula Boromelo
Ana Paula Boromelo
OFOsvaldo Ferrarese-Filho
Osvaldo Ferrarese-Filho
The sulfate assimilation pathway is essential for plant metabolism and represents a promising herbicide target. O-Acetylserine (thiol) lyase, the final enzyme in this pathway, plays a key regulatory role. This study investigated the selective effects of S-benzyl-L-cysteine, a novel O-acetylserine (thiol) lyase inhibitor, on maize (Zea mays) and sourgrass (Digitaria insularis), a glyphosate-resistant weed. Seeds and seedlings were treated with S-benzyl-L-cysteine (0.0-5.0 mM), and germination, growth, O-acetylserine (thiol) lyase activity, and photosynthetic parameters were evaluated. Sourgrass was highly sensitive to S-benzyl-L-cysteine, with germination reduced by 53 % at 2.0 mM and nearly abolished at 5.0 mM. Maize showed tolerance up to 2.0 mM, with growth suppression only at 5.0 mM. S-Benzyl-L-cysteine inhibited O-acetylserine (thiol) lyase activity in roots of both species, more intensely in sourgrass. In leaves, O-acetylserine (thiol) lyase activity increased only in maize, suggesting a compensatory response. Photosynthetic analyses revealed mild effects in maize but pronounced impairment in sourgrass. At 2.0 mM S-benzyl-L-cysteine, maize exhibited moderate reductions in CO2 assimilation (-18 %), stomatal conductance (-21 %), transpiration (-16 %), and the effective quantum yield of PSII (-15 %), while intercellular CO2 concentration, maximum assimilation rate, maximum carboxylation rate, maximum electron transport rate, and electron transport rate remained unaffected. In sourgrass, S-benzyl-L-cysteine caused sharp declines in CO2 assimilation (-76 %), stomatal conductance (-81 %), transpiration (-79 %), intercellular CO2 concentration (-63 %), maximum assimilation rate (-62 %), maximum carboxylation rate (-72 %), maximum electron transport rate (-67 %), the effective quantum yield of PSII (-24 %), electron transport rate (-46 %), accompanied by a 25 % increase in non-photochemical quenching. This is the first study to reveal species-specific responses to O-acetylserine (thiol) lyase inhibition in two C4 plants, uncovering sulfur metabolic plasticity as a basis for herbicide selectivity. These findings demonstrate that S-benzyl-L-cysteine selectively impairs sourgrass photosynthesis while sparing maize, likely by differentially affecting sulfur metabolism and photoprotection. O-Acetylserine (thiol) lyase thus emerges as a promising herbicide target. Further research is needed to validate S-benzyl-L-cysteine's efficacy under field conditions.